(2002). An examination of physiological mechanisms underlying the frequency-doubling illusion. Invest Opthalmol Vis Sci
(2006). Asymmetries and visual field summaries as predictors of glaucoma in the ocular hypertension treatment study. Invest Opthalmol Vis Sci
(2002). Baseline visual field characteristics in the ocular hypertension treatment study. Ophthalmology
(2004). Central corneal thickness and measured IOP response to topical ocular hypotensive medication in the ocular hypertension treatment study.
(1997). Correlation between ocular hypertension induced by ibopamine and perimetric defect in primary open-angle glaucoma.
(2006). Detection and prognostic significance of optic disc hemorrhages during the Ocular Hypertension Treatment Study. Ophthalmology
(2008). Diagnostic accuracy of the Matrix 24-2 and original N-30 frequency-doubling technology tests compared with standard automated perimetry. Invest Opthalmol Vis Sci
(2000). Human corneal thickness and its impact on intraocular pressure measures: a review and meta-analysis approach. Surv Ophthalmol
(2007). Ibopamine stimulates -adrenergic receptors and D1 dopaminergic receptors in the eye. Curr Drug Ther
(1990). Intraocular hypertensive effects of topically administered ibopamine in eyes with hydrodynamic disorders: provocative test for glaucoma. Glaucoma
(2008). Learning effect of Humphrey matrix frequency doubling technology perimetry in patients with ocular hypertension.
(2002). Ocular hypertension induced by ibopamine early discloses glaucoma suspects among relatives of glaucomatous patients. Boll Ocul
(2007). Ocular hypertension treatment study group, European glaucoma prevention study group, validated prediction model for the development of primary openangle glaucoma in individuals with ocular hypertension. Ophthalmology
(2008). Relationship between humphrey 30-2 SITA standard test, matrix 30-2 threshold test, and Heidelberg retina tomography in ocular hypertensive and glaucoma patients.
(2004). Risk assessment in the management of patients with ocular hypertension.
(2004). The effects of 2% ibopamine eye drops on the intraocular pressure and pupil motility of patients with open-angle glaucoma.
(2002). The ocular hypertension treatment study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol
(1999). The ocular hypertension treatment study: design and baseline description of the participants. Arch Ophthalmol
(1992). The pattern electroretinogram in glaucoma and ocular hypertension.
(2008). The role of humphrey matrix testing in the early diagnosis of retinopathy in type 1 diabetes.
(2006). Topical ocular hypotensive medication and lens opacification: evidence from the ocular hypertension treatment study.
(2005). Validation of a predictive model to estimate the risk of conversion from ocular hypertension to glaucoma. Arch Ophthalmol
(2005). Water-drinking test in patients with primary open-angle glaucoma while treated with different topical medications.